home-bg_edited.jpg

DISCOVER CMTRA

A highly interactive forum

 

The Cancer Molecular Therapeutics Research Association Board of Directors is pleased to announce the location for the 2023 Molecular Therapeutics of Cancer Conference is at the
Watkins Glen Harbor Hotel in Watkins Glen, New York.
Save your dates for July 23 - 27, 2023. 
Registration updates will be released here in the upcoming year. We are looking forward to it!

 

ABOUT THE CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION

The Full Story

  • Provides a dynamic platform for the most contemporary and controversial approaches to the treatment of cancer

  • Dedicates half of the formal presentation time to questions and answers to promote rigorous discussion

  • Welcomes an active dialog among investigators from industry, academia, government and, foundations

  • Enables informal and intimate (150 participants) networking for graduate students, postdoctoral fellows, residents and, early-stage and established investigators

  • Awards the top four poster presenters with the opportunity to orally present their research and attend next year’s conference free of charge

  • Builds on the legacy of more than two decades of annual conference

CMTRA 2022 Skamania Group.JPG
 

The 2022 CMTRA Conference was held in the Skamania Lodge in Stevenson, WA. We had an incredible time in July from 17- 21, 2022! 


Congratulations to the following winners of the 2022 poster session:

Annapoorna Venkatachalam

Bingbing Li

Steven Tau

William Marsiglia


See below photos from the event and the conference program. 

Stay tuned for updates on the 2023 conference. These will be realeased soon! 

 
 
IMG_0949.JPG

ANNUAL MEETINGS

Programs

The Cancer Molecular Therapeutics Research Association [CMTRA] was created in 2008 to organize and host the annual Molecular Therapeutics of Cancer meeting. The meeting objective is to provide a forum for presentation and discussion of contemporary research in the field of cancer drug development and therapy. Modeled after small Gordon-type conferences, the meeting provides an opportunity for young and established researchers to discuss and challenge current paradigms for cancer drug development and therapy, as well as a venue where novel ideas can be presented with anticipation of lively debate.

 

2022 CONFERENCE

Skamania Lodge ; 1131 SW Skamania Lodge Way, Stevenson, WA 98648

2021 CONFERENCE

Cancelled due to the COVID-19 Pandemic

Read More

2020 CONFERENCE

Cancelled due to the COVID-19 Pandemic

Read More

2019 CONFERENCE

Granlibakken Tahoe Resort & Conferenec Center, Lake Tahoe, CA

2018 CONFERENCE

Sundance, Utah

2017 CONFERENCE

Hilton Burlington Hotel, Burlington, Vermont

2016 CONFERENCE

University of Washington, Seattle, Washington

2015 CONFERENCE

Tufts University, Medford, Massachusetts

2014 CONFERENCE

Asilomar, Pacific Grove, California

2013 CONFERENCE

University of Colorado, Boulder, Colorado

2012 CONFERENCE

Princeton University

2011 CONFERENCE

The Asilomar Conference Center

2010 CONFERENCE

The Asilomar Conference Center

2009 CONFERENCE

Stanford University

2008 CONFERENCE

Princeton University

CMTRA

Officers & Board Members

​Martin McMahon, Ph.D..jpg

MARTIN MCMAHON, PH.D.

President

Cumming-Presidential Professor of Cancer Biology & Senior Director for Preclinical Translation | 

Huntsman Cancer Institute & Dept. of Dermatology | University of Utah | Salt Lake City, UT

Lori Friedman, Ph.D..jpg

LORI FRIEDMAN, PH.D.

Vice President

Chief Scientific Officer | ORIC Pharmaceuticals | South San Francisco, CA

James D. Winkler.jpg

JAMES D. WINKLER, PH.D. 

Secretary

Chief Scientific Officer | OnKure Therapeutics

Placzek Photo.png

WILLIAM J. PLACZEK, PH.D. 

Treasurer

Associate Professor | Department of Biochemistry and Molecular Genetics; Director | Central Alabama High-Field NMR Facility; Co-Director | Structural Biology Shared Facility, Cancer Center | The University of Alabama at Birmingham

Peter Houghton, Ph.D..jpg

PETER HOUGHTON, PH.D.

Board Member

Director | Greehey Children's Cancer Research Institute | UT Health at San Antonio, San Antonio, TX 

Robert Kramer, Ph.D..png

ROBERT KRAMER, PH.D.

Board Member

RAKramer Consulting LLC | Newton, PA 

Mary-Ann Bjornsti, Ph.D..jpg

MARY-ANN BJORNSTI, PH.D.

Board Member

Professor & Chair Newman H Waters Chair of Clinical Pharmacology | Department of Pharmacology & Toxicology | University of Alabama at Birmingham

Phillip A. Dennis, M.D., Ph.D..jpg

PHILLIP A. DENNIS, M.D., PH.D.

Board Member

Vice President Lung Cancer | Sanofi Oncology

Shiva Malek, Ph.D._edited.jpg

SHIVA MALEK, PH.D.

Board Member

Global Head, Oncology | Novartis Institute of Biomedical Research

Zahid H. Siddik, Ph.D..jpg

ZAHID H. SIDDIK, PH.D.

Board Member

Professor of Medicine | Pharmacology Department of Experimental Therapeutics | MD Anderson Cancer Center | Houston, TX

Eli M. Wallace, Ph.D..jpg

ELI M. WALLACE, PH.D.

Board Member

Chief Scientific Officer, Oncology | BridgeBio | Dallas, TX

Bob Abraham.jpg

BOB ABRAHAM, PH.D.

Board Member

Executive Vice President | Head of Cancer Biology | Odyssey Therapeutics

Emeritus Board Members: 

  • Alan Eastman, Ph.D. - Professor Emeritus | Norris Cotton Cancer Center | Dartmouth College | Hanover, NH

  • John A. Hickman, D.Sc. - Agon Consulting, Paris 

  • Branimir I. Sikic, M.D. - Director | Stanford Clinical & Translational Research Unit; Co-director | Stanford University School of Medicine | Stanford, CA 

 

CONTACT US

Tatum Street

Collaborating at Work